CStone receives CTA approval in China to start Phase I trial for FGFR4 inhibitor BLU-554 (CS3008) Life Science
I-Mab Receives IND Approval from the US FDA to Initiate Clinical Trials for Its Proprietary TJC4, a Potential Global Best-in-Class Anti-CD47 Monoclonal Antibody Life Science
Arena Pharmaceuticals Announces Closing of Global License Agreement with United Therapeutics for Ralinepag Life Science
Vangst just raised $10 million to plug more people into the fast-growing cannabis industry Cannabis, Life Science
Applied DNA Signs Memorandum of Understanding with Sun Chemical Supply Company to Bring CertainT® Authentication Platform to Textile Manufacturers in Asia Life Science